Active — Not RecruitingNot Applicable

Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

United States1,500 participantsStarted 2001-09-05

Plain-language summary

Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Registered MDACC patients diagnosed with MEN1 or MEN2.
✓. Close relatives of registered MDACC MEN patients.

What they're measuring

Contribution of New and Prospective Data to Existing Database Library for Patients with MEN1 and MEN2 by Completion of Health Questionnaires

Timeframe: 25 years

Trial details

NCT IDNCT03048279

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-01

View on ClinicalTrials.gov More Multiple Endocrine Neoplasia Syndromes trials